Skip to Content

Yervoy Side Effects

Generic Name: ipilimumab

Note: This page contains side effects data for the generic drug ipilimumab. It is possible that some of the dosage forms included below may not apply to the brand name Yervoy.

It is possible that some side effects of Yervoy may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to ipilimumab: intravenous solution

As well as its needed effects, ipilimumab (the active ingredient contained in Yervoy) may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking ipilimumab, check with your doctor or nurse immediately:

More common
  • Bloody, black, or tarry stools
  • diarrhea
  • fever
  • heartburn
  • indigestion
  • itching skin
  • nausea
  • rash
  • severe stomach pain, cramping, or burning
  • unusual tiredness or weakness
  • vomiting
  • vomiting of material that looks like coffee grounds, severe and continuing
  • watery or bloody diarrhea
Less common
  • Abdominal or stomach tenderness
  • blistering, crusting, irritation, itching, or reddening of the skin
  • bloody or cloudy urine
  • blurred vision or other changes in vision
  • burning, dry, or itching eyes
  • burning, tingling, numbness or pain in the hands, arms, feet, or legs
  • chest pain
  • chills
  • clay-colored stools
  • cough
  • cracked, dry, or scaly skin
  • dark urine
  • darkening of the skin
  • decreased appetite
  • decreased frequency or amount of urine
  • difficulty with breathing, chewing, swallowing, or talking
  • dizziness
  • double vision
  • drooping eyelids
  • drowsiness
  • eye discharge or excessive tearing
  • eye pain or sensitivity to light
  • fainting
  • headache, possibly severe
  • hives or welts
  • loss of appetite
  • mental depression
  • muscle weakness
  • pain, itching, burning, swelling, bleeding, or a lump under the skin where the needle was placed
  • painful or difficult urination
  • redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
  • sensation of pins and needles
  • severe tiredness
  • shortness of breath
  • sore throat
  • sores, ulcers, or white spots on the lips or in the mouth
  • stabbing pain
  • swelling of the face, feet, or lower legs
  • swollen glands
  • trouble breathing
  • unusual bleeding or bruising
  • unusual weight gain
  • yellow eyes or skin
  • Anxiety
  • bloating
  • blue or pale skin
  • chest pain, possibly moving to the left arm, neck, or shoulder
  • confusion
  • constipation
  • difficulty with moving
  • fast heartbeat
  • general feeling of discomfort or illness
  • increased blood pressure
  • increased thirst
  • lower back or side pain
  • muscle pain or stiffness
  • muscle weakness
  • pain or burning in the throat
  • pain, swelling, or redness in the joints
  • pains in the stomach or side, possibly radiating to the back
  • skin irritation or rash, including rash that looks like psoriasis
  • sores, welting, or blisters on the skin
  • stiff neck or back
Incidence not known
  • Back, leg, or stomach pains
  • bleeding gums
  • general body swelling
  • inability to move the arms and legs
  • nosebleeds
  • throbbing pain

For Healthcare Professionals

Applies to ipilimumab: intravenous solution


The most common side effects were diarrhea, rash, pruritus, fatigue, nausea, vomiting, decreased appetite, abdominal pain, and colitis.[Ref]


Common (1% to 10%): Sepsis, oral candidiasis, cellulitis, contrast media allergy, seasonal allergy
Uncommon (0.1% to 1%): Septic shock, cytokine release syndrome, positive antinuclear antibody
Rare (less than 0.1%): Sarcoidosis[Ref]


Common (1% to 10%): Infectious hepatitis, increased blood bilirubin, increased alanine aminotransferase, increased aspartate aminotransferase, abnormal hepatic function, hepatic failure, hepatomegaly, jaundice
Uncommon (0.1% to 1%): Autoimmune hepatitis, increased gamma-glutamyltransferase[Ref]


Common (1% to 10%): Hypotension, flushing, hypertension, hematoma, venous thrombosis, hemorrhage, lymphedema, hot flush
Uncommon (0.1% to 1%): Orthostatic hypotension, pericardial effusion
Rare (less than 0.1%): Myocarditis, cardiomyopathy, angiopathy, peripheral ischemia, vasculitis, temporal arteritis, Raynaud's phenomenon[Ref]


Very common (10% or more): Pruritus (up to 33%), rash (up to 30%)
Common (1% to 10%): Erythema, vitiligo, alopecia, dry skin, night sweats, dermatitis, urticaria, eczema, skin hypopigmentation, contusion, excoriation
Uncommon (0.1% to 1%): Toxic epidermal necrolysis, leukocytoclastic vasculitis, skin exfoliation, erythema multiforme, psoriasis, palmar-plantar erythrodysesthesia syndrome, erythema nodosum, hair color changes[Ref]


Common (1% to 10%): Decreased blood corticotrophin, hypopituitarism (including hypophysitis), hypothyroidism, adrenal insufficiency, hyperthyroidism
Uncommon (0.1% to 1%): Increased blood thyroid stimulating hormone, decreased blood cortisol, decreased blood testosterone, hypogonadism, thyroiditis, hypoparathyroidism, decreased blood thyroid stimulating hormone, decreased blood gonadotrophin, decreased thyroxin, abnormal blood prolactin, hypocalcemia
Rare (less than 0.1%): Secondary adrenocortical insufficiency, hyperpituitarism, autoimmune thyroiditis[Ref]


Very common (10% or more): Diarrhea (up to 38%), vomiting (up to 24%), abdominal pain (up to 23%), nausea
Common (1% to 10%): Colitis, gastrointestinal hemorrhage, constipation, gastroesophageal reflux disease, stomatitis, dysphagia, retching, gastroenteritis, increased lipase, large intestine perforation, proctitis
Uncommon (0.1% to 1%): Increased blood amylase, gastrointestinal perforation, large intestinal ulcer, esophagitis, ileus, diverticulitis, gastric ulcer, enterocolitis, pancreatitis, peritonitis[Ref]


Common (1% to 10%): Lymphoadenopathy, eosinophilia, neutropenia, thrombocytopenia, anemia, lymphopenia
Uncommon (0.1% to 1%): Hemolytic anemia, leucopenia, lymphocytosis
Rare (less than 0.1%): Polycythemia[Ref]

Nervous system

Very common (10% or more): Headache (up to 15%)
Common (1% to 10%): Lethargy, tremor, brain edema, cranial neuropathy, peripheral sensory neuropathy, aphasia, dizziness
Uncommon (0.1% to 1%): Guillain-Barré syndrome, meningitis (aseptic), syncope, ataxia, tremor, myoclonus, dysarthria, myasthenia gravis-like syndrome
Rare (less than 0.1%): Meninginism, autoimmune central neuropathy (encephalitis), neurosensory hypoacusis[Ref]


Common (1% to 10%): Blurred vision, conjunctivitis, uveitis, eye pain, dry eye
Uncommon (0.1% to 1%): Vitreous hemorrhage, iritis, reduced visual acuity, foreign body sensation in eyes, blepharitis
Rare (less than 0.1%): Episcleritis, scleritis, eye edema, ocular myositis[Ref]


Very common (10% or more): Fatigue (up to 42%), pyrexia (up to 13%)
Common (1% to 10%): Chest pain, chills, asthenia, edema, pain, influenza-like illness
Uncommon (0.1% to 1%): Multi-organ failure, infusion related reaction, systemic inflammatory response syndrome, mucosal inflammation[Ref]


Common (1% to 10%): Renal failure, hematuria, increased blood creatinine
Uncommon (0.1% to 1%): Glomerulonephritis, renal tubular acidosis, urinary tract infection
Rare (less than 0.1%) Autoimmune nephritis, proteinuria[Ref]


Very common (10% or more): Cough (up to 17%)
Common (1% to 10%): Upper respiratory tract infection, lower respiratory tract infection, oropharyngeal pain, wheezing, nasal disorder, sinus, congestion, dyspnea
Uncommon (0.1% to 1%): Respiratory failure, acute respiratory distress syndrome, lung infiltration, pulmonary edema, pneumonitis, allergic rhinitis[Ref]


Uncommon (0.1% to 1%): Amenorrhea[Ref]


Rare (less than 0.1%): Hypersensitivity[Ref]


Very common (10% or more): Injection site reaction (up to 50%)
Common (1% to 10%): Vaccination site reaction[Ref]


Very common (10% or more): Decreased appetite (up to 27%)
Common (1% to 10%): Hypokalemia, hypoglycemia, hypoalbuminemia, hyponatremia, decreased weight, dehydration
Uncommon (0.1% to 1%): Alkalosis, hypophosphatemia, tumor lysis syndrome
Rare (less than 0.1%): Tumor lysis syndrome[Ref]


Common (1% to 10%): Myalgia, muscle spasms.
Uncommon (0.1% to 1%): Arthralgia, musculoskeletal pain, arthritis.
Rare (less than 0.1%): Polymyalgia rheumatica, myositis, polymyositis.[Ref]


Common (1% to 10%): Tumor pain, cancer pain
Frequency not reported: Paraneoplastic syndrome[Ref]


Very common (10% or more): Insomnia (up to 12%)
Common (1% to 10%): Depression, anxiety, decreased libido, confusional state
Uncommon (0.1% to 1%): Mental status changes[Ref]


1. "Product Information. Yervoy (ipilimumab)." Bristol-Myers Squibb, Princeton, NJ.

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. Cerner Multum, Inc. "Australian Product Information." O 0

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.